SLC7A11-mediated ferroptosis inhibition not only plays a role in tumor development caused by loss of tumor suppressors (such as p53 and BAP1) but also contributes to oncogene-driven tumorigenesis (34). This evidence concerns the gene TP53 and neoplasm.